Literature DB >> 11845132

Consideration of perfusion reserve in viability assessment by myocardial Tl-201 rest-redistribution SPECT: a quantitative study with dual-isotope SPECT.

Jin Chul Paeng1, Dong Soo Lee, Gi Jeong Cheon, Ki Bong Kim, Jeong Seok Yeo, June-Key Chung, Myung Chul Lee.   

Abstract

BACKGROUND: To optimize the use of thallium 201 rest-redistribution study in Tl-201/technetium 99m sestamibi dual-isotope single photon emission computed tomography (SPECT), the predictability of Tl-201 rest-redistribution for viable myocardium was examined according to the degree of perfusion reserve. METHODS AND
RESULTS: Twenty patients with both unstable angina and left ventricular dysfunction were enrolled. Tl-201 rest-dipyridamole stress Tc-99m sestamibi gated SPECT/Tl-201 24-hour redistribution SPECT was performed before and 3 months after coronary artery bypass grafting. Through use of a 20-segment model, segmental stress perfusion, rest perfusion, and systolic thickening were quantified on gated SPECT by means of automatic quantitation software. Perfusion was expressed as the average percentage of maximal radioactivity uptake. To represent perfusion reserve, the perfusion difference score (PDS) was defined as rest perfusion minus stress perfusion. A low PDS indicated little or no inducible ischemia, and a high PDS indicated inducible ischemia. In dysfunctional myocardium, viability was defined by the improvement of thickening after coronary artery bypass grafting. The overall predictability of Tl-201 redistribution for viability was 0.709 of the area under the curve (AUC) in receiver operating characteristic analysis. With a cutoff of 7, predictability was significantly better in the low PDS group (AUC = 0.785) than in the high PDS group (AUC = 0.582).
CONCLUSIONS: The predictability of Tl-201 rest-redistribution for viability differs according to perfusion reserve. It was more reliable for dysfunctional myocardium with persistent perfusion decrease. On the basis of the continuum hypothesis of chronic stunning and hibernation, we suggest that dysfunctional myocardium with persistent perfusion decrease should be assessed by Tl-201 redistribution SPECT.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845132     DOI: 10.1067/mnc.2002.119688

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  23 in total

Review 1.  Concept and evaluation of hibernating myocardium.

Authors:  S H Rahimtoola
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

Review 2.  Myocardial 'stunning' in man.

Authors:  R Bolli
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

Review 3.  Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium).

Authors:  P G Camici; W Wijns; M Borgers; R De Silva; R Ferrari; J Knuuti; A A Lammertsma; A J Liedtke; G Paternostro; S F Vatner
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

4.  The hibernating myocardium.

Authors:  S H Rahimtoola
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

5.  Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.

Authors:  G R Heyndrickx; R W Millard; R J McRitchie; P R Maroko; S F Vatner
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

6.  Incremental prognostic value of rest-redistribution (201)Tl single-photon emission computed tomography.

Authors:  T Sharir; D S Berman; H C Lewin; J D Friedman; I Cohen; R Miranda; R D Agafitei; G Germano
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization?

Authors:  A N Kitsiou; G Srinivasan; A A Quyyumi; R M Summers; S L Bacharach; V Dilsizian
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

Review 8.  Hibernating myocardium.

Authors:  G Heusch
Journal:  Physiol Rev       Date:  1998-10       Impact factor: 37.312

Review 9.  A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina.

Authors:  S H Rahimtoola
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

10.  Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning?

Authors:  Y T Shen; S F Vatner
Journal:  Circ Res       Date:  1995-03       Impact factor: 17.367

View more
  5 in total

1.  FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against.

Authors:  Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

2.  Is it Feasible to Use the Commercially Available Autoquantitation Software for the Evaluation of Myocardial Viability on Small-Animal Cardiac F-18 FDG PET Scan?

Authors:  Kisoo Pahk; Sun Young Oh; Eugene Jeong; Sung Ho Lee; Sang Keun Woo; Jung Woo Yu; Jae Gol Choe; Gi Jeong Cheon
Journal:  Nucl Med Mol Imaging       Date:  2013-05-08

3.  Time course of functional recovery after coronary artery bypass grafting surgery according to the preoperative reversibility of perfusion impairment on myocardial SPECT.

Authors:  Jin Chul Paeng; Dong Soo Lee; Won Jun Kang; Byeong Il Lee; Ki-Bong Kim; June-Key Chung; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-18       Impact factor: 9.236

4.  Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.

Authors:  Wei He; Wanda Acampa; Ciro Mainolfi; Francesco Menna; Anna Rita Sorrentino; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

5.  Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.